Cargando…
P1201: ZANUBRUTINIB PLUS RCHOP(ZR-CHOP) REGIMEN ACHIEVES HIGH COMPLETE RESPONSE RATE IN THE TREATMENT OF NEWLY-DIAGNOSED DOUBLE-EXPRESSION DIFFUSE LARGE B CELL LYMPHOMA
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429698/ http://dx.doi.org/10.1097/01.HS9.0000847668.08542.45 |
| _version_ | 1784779539958726656 |
|---|---|
| author | He, Q. Xie, L. Zhao, R. Ma, J. Liu, C. Chen, C. Wang, H. Lu, K. Li, J. Zhao, C. Shan, N. Xing, L. Li, Z. |
| author_facet | He, Q. Xie, L. Zhao, R. Ma, J. Liu, C. Chen, C. Wang, H. Lu, K. Li, J. Zhao, C. Shan, N. Xing, L. Li, Z. |
| author_sort | He, Q. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429698 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94296982022-08-31 P1201: ZANUBRUTINIB PLUS RCHOP(ZR-CHOP) REGIMEN ACHIEVES HIGH COMPLETE RESPONSE RATE IN THE TREATMENT OF NEWLY-DIAGNOSED DOUBLE-EXPRESSION DIFFUSE LARGE B CELL LYMPHOMA He, Q. Xie, L. Zhao, R. Ma, J. Liu, C. Chen, C. Wang, H. Lu, K. Li, J. Zhao, C. Shan, N. Xing, L. Li, Z. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429698/ http://dx.doi.org/10.1097/01.HS9.0000847668.08542.45 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters He, Q. Xie, L. Zhao, R. Ma, J. Liu, C. Chen, C. Wang, H. Lu, K. Li, J. Zhao, C. Shan, N. Xing, L. Li, Z. P1201: ZANUBRUTINIB PLUS RCHOP(ZR-CHOP) REGIMEN ACHIEVES HIGH COMPLETE RESPONSE RATE IN THE TREATMENT OF NEWLY-DIAGNOSED DOUBLE-EXPRESSION DIFFUSE LARGE B CELL LYMPHOMA |
| title | P1201: ZANUBRUTINIB PLUS RCHOP(ZR-CHOP) REGIMEN ACHIEVES HIGH COMPLETE RESPONSE RATE IN THE TREATMENT OF NEWLY-DIAGNOSED DOUBLE-EXPRESSION DIFFUSE LARGE B CELL LYMPHOMA |
| title_full | P1201: ZANUBRUTINIB PLUS RCHOP(ZR-CHOP) REGIMEN ACHIEVES HIGH COMPLETE RESPONSE RATE IN THE TREATMENT OF NEWLY-DIAGNOSED DOUBLE-EXPRESSION DIFFUSE LARGE B CELL LYMPHOMA |
| title_fullStr | P1201: ZANUBRUTINIB PLUS RCHOP(ZR-CHOP) REGIMEN ACHIEVES HIGH COMPLETE RESPONSE RATE IN THE TREATMENT OF NEWLY-DIAGNOSED DOUBLE-EXPRESSION DIFFUSE LARGE B CELL LYMPHOMA |
| title_full_unstemmed | P1201: ZANUBRUTINIB PLUS RCHOP(ZR-CHOP) REGIMEN ACHIEVES HIGH COMPLETE RESPONSE RATE IN THE TREATMENT OF NEWLY-DIAGNOSED DOUBLE-EXPRESSION DIFFUSE LARGE B CELL LYMPHOMA |
| title_short | P1201: ZANUBRUTINIB PLUS RCHOP(ZR-CHOP) REGIMEN ACHIEVES HIGH COMPLETE RESPONSE RATE IN THE TREATMENT OF NEWLY-DIAGNOSED DOUBLE-EXPRESSION DIFFUSE LARGE B CELL LYMPHOMA |
| title_sort | p1201: zanubrutinib plus rchop(zr-chop) regimen achieves high complete response rate in the treatment of newly-diagnosed double-expression diffuse large b cell lymphoma |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429698/ http://dx.doi.org/10.1097/01.HS9.0000847668.08542.45 |
| work_keys_str_mv | AT heq p1201zanubrutinibplusrchopzrchopregimenachieveshighcompleteresponserateinthetreatmentofnewlydiagnoseddoubleexpressiondiffuselargebcelllymphoma AT xiel p1201zanubrutinibplusrchopzrchopregimenachieveshighcompleteresponserateinthetreatmentofnewlydiagnoseddoubleexpressiondiffuselargebcelllymphoma AT zhaor p1201zanubrutinibplusrchopzrchopregimenachieveshighcompleteresponserateinthetreatmentofnewlydiagnoseddoubleexpressiondiffuselargebcelllymphoma AT maj p1201zanubrutinibplusrchopzrchopregimenachieveshighcompleteresponserateinthetreatmentofnewlydiagnoseddoubleexpressiondiffuselargebcelllymphoma AT liuc p1201zanubrutinibplusrchopzrchopregimenachieveshighcompleteresponserateinthetreatmentofnewlydiagnoseddoubleexpressiondiffuselargebcelllymphoma AT chenc p1201zanubrutinibplusrchopzrchopregimenachieveshighcompleteresponserateinthetreatmentofnewlydiagnoseddoubleexpressiondiffuselargebcelllymphoma AT wangh p1201zanubrutinibplusrchopzrchopregimenachieveshighcompleteresponserateinthetreatmentofnewlydiagnoseddoubleexpressiondiffuselargebcelllymphoma AT luk p1201zanubrutinibplusrchopzrchopregimenachieveshighcompleteresponserateinthetreatmentofnewlydiagnoseddoubleexpressiondiffuselargebcelllymphoma AT lij p1201zanubrutinibplusrchopzrchopregimenachieveshighcompleteresponserateinthetreatmentofnewlydiagnoseddoubleexpressiondiffuselargebcelllymphoma AT zhaoc p1201zanubrutinibplusrchopzrchopregimenachieveshighcompleteresponserateinthetreatmentofnewlydiagnoseddoubleexpressiondiffuselargebcelllymphoma AT shann p1201zanubrutinibplusrchopzrchopregimenachieveshighcompleteresponserateinthetreatmentofnewlydiagnoseddoubleexpressiondiffuselargebcelllymphoma AT xingl p1201zanubrutinibplusrchopzrchopregimenachieveshighcompleteresponserateinthetreatmentofnewlydiagnoseddoubleexpressiondiffuselargebcelllymphoma AT liz p1201zanubrutinibplusrchopzrchopregimenachieveshighcompleteresponserateinthetreatmentofnewlydiagnoseddoubleexpressiondiffuselargebcelllymphoma |